POST Online Media Lite Edition


NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

FDA recommends Moderna's COVID-19 vaccine booster for at-risk adults

Christian Fernsby |
Vaccine advisors to the U.S. Food and Drug Administration (FDA) voted unanimously to recommend emergency use authorization of a booster dose of Moderna's COVID-19 vaccine.

Article continues below

The FDA's Vaccines and Related Biological Products Advisory Committee recommended use of a booster dose for people over 65, people between the ages of 18 and 64 who are at high risk of severe COVID-19, as well as people who are at risk of serious COVID-19 because of their jobs, or living situation.

The population recommended for Moderna's booster is the same population that Pfizer's booster was authorized for last month.

Unlike Pfizer, Moderna is proposing to use a half-dose of the vaccine for a booster given at least six months after the prime dose, rather than an additional full dose.

A U.S. Food and Drug Administration (FDA) advisory committee on Friday voted to recommend authorizing a second dose of Johnson & Johnson's COVID-19 vaccine.

What to read next

FDA seeks permanent injunctions against two stem cell clinics
Moderna says its coronavirus vaccine candidate is stable in standard home refrigerator
U.S. authorizes Moderna's coronavirus vaccine for emergency use